0 773

Cited 25 times in

Cited 34 times in

Slice-selective learning for Alzheimer's disease classification using a generative adversarial network: a feasibility study of external validation

DC Field Value Language
dc.contributor.authorKim, Han Woong-
dc.contributor.authorLee, Ha Eun-
dc.contributor.authorLee, Sangwon-
dc.contributor.authorOh, Kyeong Taek-
dc.contributor.authorYun, Mijin-
dc.contributor.authorYoo, Sun Kook-
dc.date.accessioned2020-10-04T16:48:50Z-
dc.date.available2020-10-04T16:48:50Z-
dc.date.created2021-03-18-
dc.date.issued2020-08-
dc.identifier.issn1619-7070-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/179681-
dc.description.abstractPurpose The aim of this feasibility study was to use slice selective learning using a Generative Adversarial Network for external validation. We aimed to build a model less sensitive to PET imaging acquisition environment, since differences in environments negatively influence network performance. To investigate the slice performance, each slice evaluation was performed. Methods We trained our model using a 18F-fluorodeoxyglucose ([F-18]FDG) PET/CT dataset obtained from the Alzheimer&apos;s Disease Neuroimaging Initiative (ADNI) database and tested the model with a Severance Hospital dataset. We applied slice selective learning to reduce computational cost and to extract unbiased features. We extracted features of Alzheimer&apos;s disease (AD) and normal cognitive (NC) condition using a Boundary Equilibrium Generative Adversarial Network (BEGAN) for stable convergence. Then, we utilized these features to train a support vector machine (SVM) classifier to distinguish AD from NC. Results The slice range that covered the posterior cingulate cortex (PCC) using double slices showed the best performance. The accuracy, sensitivity, and specificity of our proposed network was 94.33%, 91.78%, and 97.06% using the Severance dataset and 94.82%, 92.11%, and 97.45% using the ADNI dataset. The performance on the two independent datasets showed no statistical difference (p > 0.05). Moreover, there was a statistical difference in the performance between using two slices and one slice as input (p < 0.05). Conclusions Our model learned the generalized features of AD and NC for external validation when appropriate slices were selected. This study showed the feasibility of this model with consistent performance when tested using datasets acquired from a variety of image-acquisition environments.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherSpringer-Verlag Berlin-
dc.relation.isPartOfEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING-
dc.relation.isPartOfEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleSlice-selective learning for Alzheimer&apos;s disease classification using a generative adversarial network: a feasibility study of external validation-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Medical Engineering (의학공학교실)-
dc.contributor.googleauthorKim, Han Woong-
dc.contributor.googleauthorLee, Ha Eun-
dc.contributor.googleauthorLee, Sangwon-
dc.contributor.googleauthorOh, Kyeong Taek-
dc.contributor.googleauthorYun, Mijin-
dc.contributor.googleauthorYoo, Sun Kook-
dc.identifier.doi10.1007/s00259-019-04676-y-
dc.relation.journalcodeJ00833-
dc.identifier.eissn1619-7089-
dc.identifier.pmid31980910-
dc.subject.keywordAlzheimer&apos-
dc.subject.keywords disease-
dc.subject.keyword[F-18] FDG PET-
dc.subject.keywordCT-
dc.subject.keywordGenerative Adversarial Network-
dc.subject.keywordExternal validation-
dc.subject.keywordFeasibility study-
dc.contributor.alternativeNameYoo, Sun Kook-
dc.contributor.affiliatedAuthorKim, Han Woong-
dc.contributor.affiliatedAuthorLee, Ha Eun-
dc.contributor.affiliatedAuthorOh, Kyeong Taek-
dc.contributor.affiliatedAuthorYun, Mijin-
dc.contributor.affiliatedAuthorYoo, Sun Kook-
dc.identifier.scopusid2-s2.0-85078328950-
dc.identifier.wosid000509164500001-
dc.citation.volume47-
dc.citation.number9-
dc.citation.startPage2197-
dc.citation.endPage2206-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Vol.47(9) : 2197-2206, 2020-08-
dc.identifier.rimsid68652-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorAlzheimer&apos-
dc.subject.keywordAuthors disease-
dc.subject.keywordAuthor[F-18] FDG PET-
dc.subject.keywordAuthorCT-
dc.subject.keywordAuthorGenerative Adversarial Network-
dc.subject.keywordAuthorExternal validation-
dc.subject.keywordAuthorFeasibility study-
dc.subject.keywordPlusGLUCOSE-METABOLISM-
dc.subject.keywordPlusFDG-PET-
dc.subject.keywordPlusBRAIN-
dc.type.docTypeArticle-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryRadiology, Nuclear Medicine & Medical Imaging-
dc.relation.journalResearchAreaRadiology, Nuclear Medicine & Medical Imaging-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Nuclear Medicine (핵의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Medical Engineering (의학공학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.